ERYtech Pharma Presents a New Advance in the Treatment of Sickle Cell Anaemia
LYON, France & PHILADELPHIA--(BUSINESS WIRE)--ERYtech Pharma has been chosen to present the first pre-clinical results obtained with its product GR-ARA1 on sickle cell anaemia during the 50th annual congress of the American Society of Hematology (ASH), to be held in San Francisco (USA) from 6 to 9 December 2008.